ibi351
innovent biologics
['ibi351', 'innovent']
#innovent presents clinical data of phase i study for #ibi351 (#krasg12cinhibitor) as #monotherapy for #solidtumors at the #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.